Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bausch Health
Bausch Health
B+L Rumored to be Looking at Potential Sale to Fully Separate from Parent Company
Medical Devices and Diagnostics Industry
Mon, 09/16/24 - 10:26 pm
Bausch + Lomb
Medtech
Bausch Health
Why Shares of Bausch Health Soared Wednesday
Motley Fool
Wed, 05/17/23 - 10:42 pm
Bausch Health
IBS
Xifaxan
patents
legal
On its annual list of price hike offenders, ICER calls out Bausch's Xifaxan, J&J's Invega
Fierce Pharma
Wed, 12/7/22 - 10:10 am
ICER
drug pricing
Bausch Health
Xifaxan
JNJ
Invega
Bausch takes hit in Xifaxan patent feud, potentially paving the way for Norwich's IBS-D generic
Fierce Pharma
Mon, 08/1/22 - 10:33 am
Bausch Health
IBS-d
Xifaxan
legal
Norwich Pharmaceuticals
generics
Biotech IPO freeze continues as second quarter is slowest in more than a decade
MedCity News
Wed, 07/6/22 - 10:38 am
IPOs
biotech
Solta Medical
Bausch Health
Joe Papa resigns as chair of Bausch Health as billionaire John Paulson takes over
Endpoints
Fri, 06/24/22 - 10:39 am
Bausch Health
Joe Papa
Pharma CEOs
Bausch Health stock plummets even as company looks to start 'new chapter'
Endpoints
Tue, 05/10/22 - 10:45 pm
Bausch Health
spinoff
FDA knocks Bausch for misleading promotion of psoriasis drug on Lifetime show
RAPS.org
Tue, 04/12/22 - 08:42 pm
Bausch Health
FDA
OPDP
psoriasis
Doubrii
Bausch + Lomb’s IPO plans come into focus as BHC prepares to split into three
MedCity News
Sun, 01/16/22 - 03:47 am
Bausch Health
IPOs
JPM22, Day 3: In short order, Perrigo part of a new landscape; Legend, J&J prep for cilta-cel launch
Fierce Pharma
Wed, 01/12/22 - 11:22 pm
JPMHC 2022
Bausch Health
Amgen
Eli Lilly
Perrigo
JNJ
Legend Biotech
Bausch pays whopping $300M to settle Glumetza pay-for-delay lawsuit after 800% price hike
Fierce Biotech
Sat, 09/11/21 - 10:24 pm
Bausch Health
Glumetza
pay-for-delay
diabetes
Bausch boosted ahead of eye spin-off
EP Vantage
Thu, 04/15/21 - 10:09 am
Bausch Health
NOV03
Bausch & Lomb
Drugmaker Bausch to sell stake in Egypt's Amoun Pharma for $740 million
Reuters
Wed, 03/31/21 - 10:42 am
Bausch Health
Amoun
ADQ
M&A
Bausch Health takes option to buy all ophthalmology assets of Allegro
Pharma Letter
Mon, 09/21/20 - 10:53 am
Bausch Health
Allergro Ophthalmics
ophthalmology
Corporate and regulatory developments over the Christmas period
EP Vantage
Thu, 01/2/20 - 11:39 pm
Astellas
M&A
Qiagen
AstraZeneca
Bausch Health
BeiGene
Celyad
Immunomedics
Merck
Merck KGaA
Ono Pharmaceutical
Pfizer
Pharming
Xyphos Biosciences
31 biopharmas at high risk of bankruptcy in 2020
Biopharma Dive
Wed, 11/20/19 - 10:18 am
bankruptcy
Teva Pharmaceutical
Bausch Health
Novavax
Why Bausch Health Companies Stock Sank Today
Motley Fool
Tue, 10/1/19 - 11:01 pm
Bausch Health
Novartis
Sandoz
Xifaxan
patents
Bausch Health Companies Posts Strongest Organic Growth in 3 Years
Motley Fool
Mon, 05/6/19 - 07:25 pm
Bausch Health
earnings
Salix grabs ex-Asia rights to Mitsubishi Tanabe autoimmune drug
Fierce Biotech
Thu, 04/25/19 - 10:37 am
Salix
Mitsubishi Tanabe Pharma
amiselimod
Bausch Health
autoimmune disease
ulcerative colitis
Mark Your Calendar For These February PDUFA Dates
Yahoo/Benzinga
Sat, 02/2/19 - 12:31 pm
FDA
DWP-450
Evolus
MOTIF BIO PLC/S ADR
Iclaprim
Bausch Health
Duobrii
Merck
Keytruda
Incyte
Novartis
ruxolitinib
Novo Nordisk
N8-GP
Pages
1
2
next ›
last »